Financials
Value Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26Q3, 26 TTM Selling/general/admin expenses 129.93 K216.89 K—271.51 K205.3 K198.2 K — Research & development —————— — Operating income -129.93 K-216.89 K—-271.51 K-205.3 K-198.2 K — Non-Operating Income, Total 810.11 K2.56 M—2.45 M2.22 M2.24 M — Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses 810.11 K2.56 M—2.45 M2.22 M2.24 M — Unusual income/expense —————— — Pretax income 680.18 K2.34 M—2.18 M2.02 M2.04 M — Equity in earnings —————— — Taxes —————— — Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 680.18 K2.34 M—2.18 M2.02 M2.04 M — Discontinued operations —————— — Net income 680.18 K2.34 M—2.18 M2.02 M2.04 M — Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 633.95 K2.34 M—2.18 M2.02 M2.04 M — Basic earnings per share (Basic EPS) 0.060.08—0.070.070.07 — Diluted earnings per share (Diluted EPS) 0.060.080.250.070.070.07 — Average basic shares outstanding 5.64 M13.06 M16.18 M23.66 M23.66 M23.66 M — Diluted shares outstanding 5.64 M13.06 M16.18 M23.66 M23.66 M23.66 M — EBITDA —————— — EBIT —————— — Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) —————— —